New drug combo shows promise for tough cancers
NCT ID NCT06049212
First seen Nov 01, 2025 · Last updated May 24, 2026 · Updated 24 times
Summary
This early-stage study tests a new drug, MK-2870, alone or with pembrolizumab (and sometimes chemotherapy) in Japanese adults with advanced solid tumors or a type of lung cancer. The main goal is to check safety and find the right dose. About 30 people will take part.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NON-SMALL CELL LUNG CANCER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Aichi Cancer Center ( Site 0006)
Nagoya, Aichi-ken, 464-8681, Japan
-
Kanagawa Cancer Center ( Site 0004)
Yokohama, Kanagawa, 241-8515, Japan
-
Kansai Medical University Hospital ( Site 0007)
Hirakata, Osaka, 573-1191, Japan
-
National Cancer Center Hospital ( Site 0001)
Chuo-ku, Tokyo, 104-0045, Japan
-
National Cancer Center Hospital East ( Site 0002)
Kashiwa, Chiba, 277-8577, Japan
-
National Hospital Organization Shikoku Cancer Center ( Site 0008)
Matsuyama, Ehime, 791-0280, Japan
-
Shizuoka Cancer Center ( Site 0005)
Nagaizumi-cho,Sunto-gun, Shizuoka, 411-8777, Japan
Conditions
Explore the condition pages connected to this study.